Torrent Pharmaceuticals Completes Acquisition of JB Chemicals Shares, Now Holds 48.80% Stake

Torrent Pharmaceuticals has successfully completed its strategic acquisition of equity shares in J.B. Chemicals & Pharmaceuticals Limited, marking a significant milestone in the pharmaceutical sector consolidation. The company announced on February 3, 2026, that it has acquired the final tranche of shares under its comprehensive acquisition agreements. Final Share Acquisition Details The latest acquisition involved 92,490 equity shares of JB Chemicals, purchased from an employee of the target company. This transaction was executed in accordance with the share purchase agreement dated July 3, 2025, which was specifically designed for acquiring shares from JB Chemicals employees. Transaction Details: Specifications Shares Acquired: 92,490 equity shares Percentage of Capital: 0.06% Acquisition Date: February 3, 2026 Agreement Date: July 3, 2025 Seller: JB Chemicals Employee Completion of Acquisition Program Torrent Pharmaceuticals has confirmed that all equity shares targeted under its dual acquisition strategy have been successfully acquired. The acquisition program comprised two main agreements: the primary Share Purchase Agreement dated June 29, 2025, executed between Torrent Pharmaceuticals, Tau Investment Holdings Pte Limited, and JB Chemicals, and the supplementary employee share purchase agreement dated July 3, 2025. Current Shareholding Position Following the completion of this acquisition, Torrent Pharmaceuticals' total shareholding in JB Chemicals has reached a substantial position in the pharmaceutical company. Shareholding Summary: Details Total Shares Held: 7,83,57,892 equity shares Ownership Percentage: 48.80% Basis: Fully diluted equity share capital Status: Acquisition program completed Regulatory Compliance and Documentation The acquisition has been conducted in full compliance with SEBI regulations, specifically under Regulation 30 and Regulation 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Torrent Pharmaceuticals has maintained transparency throughout the acquisition process, with multiple intimations to stock exchanges dating back to June 29, 2025. The completion of this acquisition represents a strategic expansion for Torrent Pharmaceuticals in the pharmaceutical sector, establishing a significant stake in JB Chemicals & Pharmaceuticals Limited. The systematic approach to the acquisition, involving both institutional and employee shareholdings, demonstrates the company's comprehensive strategy for building substantial positions in target companies. Torrent Pharmaceuticals Ltd. recorded a significant block trade on the National Stock Exchange (NSE), highlighting notable institutional trading activity in the pharmaceutical sector. The transaction represents a substantial movement of shares through the block deal mechanism. Block Trade Details The block trade executed on NSE involved a considerable transaction value and volume, demonstrating institutional investor participation in Torrent Pharmaceuticals' stock. Parameter: Details Transaction Value: ₹24.83 crores Number of Shares: 61,261 shares Price per Share: ₹4,053.50 Exchange: NSE Market Significance Block trades represent large-volume transactions typically executed by institutional investors, mutual funds, or other significant market participants. These transactions are conducted through a separate window to minimize the impact on regular market trading and provide liquidity for large-scale share transfers. The execution price of ₹4,053.50 per share reflects the prevailing market conditions at the time of the transaction. Such block deals often indicate strategic portfolio adjustments by institutional investors or significant stake changes in the company. Transaction Overview The block trade mechanism allows for efficient execution of large orders without causing significant price volatility in the regular trading session. This particular transaction involving Torrent Pharmaceuticals demonstrates the continued interest of institutional investors in the pharmaceutical sector, with the substantial transaction value indicating confidence in the company's market position. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.